Orbimed Advisors LLC Merck & Co., Inc. Transaction History
Orbimed Advisors LLC
- $4.44 Billion
- Q1 2024
A detailed history of Orbimed Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,316,000 shares of MRK stock, worth $163 Million. This represents 3.91% of its overall portfolio holdings.
Number of Shares
1,316,000
Previous 1,055,000
24.74%
Holding current value
$163 Million
Previous $115 Million
50.98%
% of portfolio
3.91%
Previous 2.82%
Shares
15 transactions
Others Institutions Holding MRK
# of Institutions
3,766Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.1 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$25.6 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.5 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.7 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$6.98 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $314B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...